These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22076990)

  • 1. Inhibition of hepatitis C virus replication by Monascus pigment derivatives that interfere with viral RNA polymerase activity and the mevalonate biosynthesis pathway.
    Sun JM; Kim SJ; Kim GW; Rhee JK; Kim ND; Jung H; Jeun J; Lee SH; Han SH; Shin CS; Oh JW
    J Antimicrob Chemother; 2012 Jan; 67(1):49-58. PubMed ID: 22076990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hepatitis C virus replication by herbal extract: Phyllanthus amarus as potent natural source.
    Ravikumar YS; Ray U; Nandhitha M; Perween A; Raja Naika H; Khanna N; Das S
    Virus Res; 2011 Jun; 158(1-2):89-97. PubMed ID: 21440018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-hepatitis C virus RdRp activity and replication of novel anilinobenzothiazole derivatives.
    Peng HK; Chen WC; Lin YT; Tseng CK; Yang SY; Tzeng CC; Lee JC; Yang SC
    Antiviral Res; 2013 Oct; 100(1):269-75. PubMed ID: 23994188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of hepatitis C virus replication by protein kinase C-related kinase 2 inhibitors that block phosphorylation of viral RNA polymerase.
    Kim SJ; Kim JH; Sun JM; Kim MG; Oh JW
    J Viral Hepat; 2009 Oct; 16(10):697-704. PubMed ID: 19243496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repositioning of RdRp Inhibitors Against HCV NS5B Polymerase Utilizing Structure-Based Molecular Docking.
    Tarannum H; Nandi S
    Comb Chem High Throughput Screen; 2022; 25(4):702-719. PubMed ID: 33475069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase.
    Harikishore A; Li E; Lee JJ; Cho NJ; Yoon HS
    Mol Divers; 2015 Aug; 19(3):529-39. PubMed ID: 25862642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference of hepatitis C virus replication in cell culture by antisense peptide nucleic acids targeting the X-RNA.
    Ahn DG; Shim SB; Moon JE; Kim JH; Kim SJ; Oh JW
    J Viral Hepat; 2011 Jul; 18(7):e298-306. PubMed ID: 21692941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and evaluation of anti hepatitis C virus phytochemicals from Eclipta alba.
    Manvar D; Mishra M; Kumar S; Pandey VN
    J Ethnopharmacol; 2012 Dec; 144(3):545-54. PubMed ID: 23026306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad-spectrum non-nucleoside inhibitors for caliciviruses.
    Netzler NE; Enosi Tuipulotu D; Eltahla AA; Lun JH; Ferla S; Brancale A; Urakova N; Frese M; Strive T; Mackenzie JM; White PA
    Antiviral Res; 2017 Oct; 146():65-75. PubMed ID: 28757394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral stilbene 1,2-diamines prevent initiation of hepatitis C virus RNA replication at the outset of infection.
    Gastaminza P; Pitram SM; Dreux M; Krasnova LB; Whitten-Bauer C; Dong J; Chung J; Fokin VV; Sharpless KB; Chisari FV
    J Virol; 2011 Jun; 85(11):5513-23. PubMed ID: 21430055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fluorescence-based high-throughput screen to identify small compound inhibitors of the genotype 3a hepatitis C virus RNA polymerase.
    Eltahla AA; Lackovic K; Marquis C; Eden JS; White PA
    J Biomol Screen; 2013 Oct; 18(9):1027-34. PubMed ID: 23708123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
    Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
    Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-ulcer agent teprenone inhibits hepatitis C virus replication: potential treatment for hepatitis C.
    Ikeda M; Kawai Y; Mori K; Yano M; Abe K; Nishimura G; Dansako H; Ariumi Y; Wakita T; Yamamoto K; Kato N
    Liver Int; 2011 Jul; 31(6):871-80. PubMed ID: 21645219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A conformational mimetic approach for the synthesis of carbocyclic nucleosides as anti-HCV leads.
    Kasula M; Balaraju T; Toyama M; Thiyagarajan A; Bal C; Baba M; Sharon A
    ChemMedChem; 2013 Oct; 8(10):1673-80. PubMed ID: 23943612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the allosteric inhibition of HCV RNA-dependent RNA polymerase and implementing virtual screening for the selection of promising dual-site inhibitors with low resistance potential.
    Ismail NSM; Elzahabi HSA; Sabry P; Baselious FN; AbdelMalak AS; Hanna F
    J Recept Signal Transduct Res; 2017 Aug; 37(4):341-354. PubMed ID: 27829320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and characterization of substituted diphenyl heterocyclic compounds as potent and selective inhibitors of hepatitis C virus replication.
    Huang P; Goff DA; Huang Q; Martinez A; Xu X; Crowder S; Issakani SD; Anderson E; Sheng N; Achacoso P; Yen A; Kinsella T; Darwish IS; Kolluri R; Hong H; Qu K; Stauffer E; Goldstein E; Singh R; Payan DG; Lu HH
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1419-29. PubMed ID: 18227176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system.
    Chung RT; He W; Saquib A; Contreras AM; Xavier RJ; Chawla A; Wang TC; Schmidt EV
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9847-52. PubMed ID: 11493707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New acridone-4-carboxylic acid derivatives as potential inhibitors of hepatitis C virus infection.
    Stankiewicz-Drogon A; Palchykovska LG; Kostina VG; Alexeeva IV; Shved AD; Boguszewska-Chachulska AM
    Bioorg Med Chem; 2008 Oct; 16(19):8846-52. PubMed ID: 18801660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics and docking reveal the potency of novel GTP derivatives against RNA dependent RNA polymerase of genotype 4a HCV.
    Elfiky AA; Ismail A
    Life Sci; 2019 Dec; 238():116958. PubMed ID: 31628915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activities of amino acid derivatives of monascus pigments.
    Kim C; Jung H; Kim YO; Shin CS
    FEMS Microbiol Lett; 2006 Nov; 264(1):117-24. PubMed ID: 17020557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.